Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK", you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you. If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Goodwin Procter.

U.S. Legislative Update: Takeaways for European Pharma (European Pharmaceutical Review)

Related Content

“There’s Only One Boss”: Delaware Court of Chancery Confirms Board’s Broad Authority to Remove a CEO in Dramatic Market Basket Case

Delaware Court Awards More Than $180 Million for Breach of Commercially Reasonable Efforts Obligation in Drug Development Milestone Dispute

PTAB’s Reversal Sheds Light on Quantum Computing Patents

Four Steps to Maximize the Value of AI Innovation in Medtech

Five Steps Hotel Owners, Operators, and Management Companies Can Take to Mitigate Risk in the Face of Heightened Antitrust Scrutiny and a Wave of Lawsuits Involving Revenue-Management Tools

Life Sciences Licensing and M&A Update: Catching Up on Recent Decisions Affecting Commercially Reasonable Efforts Definitions and Post-Patent Expiration Royalty Obligations

The Rapid Rise of AI, in Five Charts

U.S. Supreme Court Significantly Curtails SEC Enforcement Forum Discretion

NYMBA Convention

Goodwin’s Elaine Blais and Diane McCabe Named to Massachusetts Lawyers Weekly Top Women of Law 2026

Eight Goodwin Partners Recognized by Benchmark Litigation’s 40 and Under List 2026

Securities Litigation Against Life Sciences Companies: Recent Trends and Updates

AI on the Docket: How AI is Transforming the Practice of Antitrust Law

Federal Circuit Bar Association’s 2026 Bench & Bar Conference

The Legal 500 US 2026 Recognizes 47 Goodwin Practices and 185 Lawyers

Lawdragon Names 10 Goodwin Partners Among 500 Leading Global Cyber Lawyers

Life Sciences

Litigation

Intellectual Property